Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents

BACKGROUND: Lemborexant has demonstrated statistically significant improvements in sleep onset and sleep maintenance compared with placebo and zolpidem tartrate extended release, measured both objectively using polysomnography and subjectively using sleep diaries, in the phase 3 clinical trial SUNRI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Shunya, Azuma, Mie Kasai, Fujimoto, Kenichi, Shibahara, Hidetoshi, Inoue, Sachie, Moline, Margaret, Ishii, Mika, Mishima, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647554/
https://www.ncbi.nlm.nih.gov/pubmed/35506334
http://dx.doi.org/10.1017/S0033291722000356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647554/
https://www.ncbi.nlm.nih.gov/pubmed/35506334
http://dx.doi.org/10.1017/S0033291722000356

Ejemplares similares